A new strategy for the diagnosis of MAGE-expressing cancers
- 7 May 2002
- journal article
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 266 (1-2), 79-86
- https://doi.org/10.1016/s0022-1759(02)00105-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCRInternational Journal of Cancer, 2001
- A real-time quantitative reverse transcriptase polymerase chain reaction (RT–PCR) to detect breast carcinoma cells in peripheral bloodAnnals of Oncology, 2001
- T‐cell recognition of melanoma‐associated antigensJournal of Cellular Physiology, 2000
- Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase–Polymerase Chain Reaction in Early-Stage Melanoma PatientsJournal of Clinical Oncology, 1999
- High frequency of expression of MAGE genes in human hepatocellular carcinomaLiver International, 1999
- Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.Journal of Clinical Oncology, 1998
- Expression of MAGE Genes in Human Colorectal CarcinomaAnnals of Surgery, 1996
- The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.Proceedings of the National Academy of Sciences, 1996
- Human esophageal carcinomas frequently express the tumor-rejection antigens ofMAGE genesInternational Journal of Cancer, 1995
- Expression of the MAGE gene family in human head‐and‐neck squamous‐cell carcinomasInternational Journal of Cancer, 1995